Walleye Trading
HBIO icon

Walleye Trading’s Harvard Bioscience HBIO Stock Holding History

Walleye Trading’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-680
Closed -$18 – 4668
2017
Q1 		$18 Sell
680
-150
-18% -$4.32K ﹤0.01% 4162
2016
Q4 		$25K Sell
830
-470
-36% -$12K ﹤0.01% 3995
2016
Q3 		$35K Buy
1,300
+780
+150% +$21.7K ﹤0.01% 3952
2016
Q2 		$15K Sell
520
-860
-62% -$27.4K ﹤0.01% 4697
2016
Q1 		$42K Buy
+1,380
New +$39.1K ﹤0.01% 3996

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Walleye Trading's HBIO Position: Q2 2017 in Review

Walleye Trading sold out of Harvard Bioscience (HBIO) in Q2 2017, closing a stake of 680 shares — an estimated $18 sold.

Walleye Trading first reported a position in HBIO in Q1 2016 and held it in 5 quarters. The position peaked at $42K in Q1 2016. 60 funds tracked by Wall St. Rank hold HBIO as of Q2 2017.

  • Walleye Trading reported no remaining Harvard Bioscience position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 680 Harvard Bioscience shares in Q2 2017, an estimated $18.
  • Walleye Trading first reported a position in Harvard Bioscience in Q1 2016 and held it in 5 quarters.
  • Walleye Trading's Harvard Bioscience position peaked at $42K in Q1 2016.
  • 60 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.